Cytek Biosciences, Inc. (CTKB) vs InMode Ltd. (INMD)
Cytek Biosciences, Inc. and InMode Ltd. are both Medical Devices companies. Cytek Biosciences, Inc. and InMode Ltd. are of similar size ($815.7M and $744.8M). Cytek Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; InMode Ltd. trades at 11.4×. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.44% against −6.71%. InMode Ltd. has the higher net margin (20.7% vs −39.0%) and the higher return on invested capital (33.8% vs −46.4%). Across the 19 metrics below, InMode Ltd. leads on 17 and Cytek Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | CTKB | INMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 53.23% | 76.52% | 56.01% |
| Operating margin | (21.60%) | 18.47% | (15.03%) |
| Net margin | (38.98%) | 20.69% | (20.40%) |
| Free cash flow margin | (5.79%) | 22.03% | (7.24%) |
| Return on equity | (23.04%) | 0.00% | (15.32%) |
| Return on assets | (17.14%) | 10.85% | (19.72%) |
| Return on invested capital | (46.36%) | 33.78% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack